Summary
- IVD Medical announced that it had purchased Ethereum (ETH) worth around $19 million.
- IVD Medical revealed plans to use Ethereum smart contracts for tokenizing healthcare assets such as pharmaceutical intellectual property rights and implementing automated revenue distribution.
- The company also stated an intention to expand its virtual asset ecosystem through the future stablecoin IVDD payment platform and a partnership with HashKey Group.
Hong Kong-listed company IVD Medical announced that it will make Ethereum (ETH) a core asset and is officially embarking on a real-world asset (RWA) tokenization strategy for the healthcare sector.
According to crypto media outlet CoinDesk on the 8th, IVD Medical revealed that it had purchased Ethereum worth approximately $19 million (around ₩2.64 billion). The platform plans to tokenize healthcare assets, such as pharmaceutical intellectual property rights, via Ethereum smart contracts and implement features like automated revenue distribution.
IVD Medical stated, "Ethereum is the world's most mature smart contract platform and has extremely high liquidity," adding, "Through Ethereum, we plan to implement ▲verification of asset ownership ▲automated revenue distribution ▲management of regulatory compliance for tokenized assets." The company also plans to use Ethereum as the settlement basis for its future stablecoin, IVDD, which it intends to develop.
Meanwhile, along with this ETH purchase, IVD Medical has entered into a partnership with Hong Kong virtual asset exchange operator HashKey Group.
Minseung Kang
minriver@bloomingbit.ioBlockchain journalist | Writer of Trade Now & Altcoin Now, must-read content for investors.
![[Exclusive] FSS to examine ZKsync coin that surged '1,000%' in three hours](https://media.bloomingbit.io/PROD/news/1da9856b-df8a-4ffc-83b8-587621c4af9f.webp?w=250)
